Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -372.85% is 171% below its 5-year average of -137.61%, around the middle of its 5-year range (-856.89%–-15.85%).
6.17% above its 12-month average of -397.37%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation.
RETURN ON EQUITY (ROE)
-372.85%
RETURN ON EQUITY (ROE) AVG TTM
-397.37%
RETURN ON EQUITY (ROE) AVG 3Y
-164.30%
RETURN ON EQUITY (ROE) AVG 5Y
-137.61%
RETURN ON EQUITY (ROE) AVG 10Y
-85.46%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+6.17%
CURRENT VS 3Y AVG
-126.93%
CURRENT VS 5Y AVG
-170.95%
CURRENT VS 10Y AVG
-336.29%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
11.23%
median of 89 covered companies
CURRENT VS SECTOR MEDIAN
-3420.12%
vs the sector median at left
PDS Biotechnology Corporation
Market Cap
$11.79M
Return on Equity (ROE)
-372.85%
TTM Avg
-397.37%
3Y Avg
-164.30%
5Y Avg
-137.61%
Market Cap
$438.82M
Return on Equity (ROE)
-28.18%
TTM Avg
-0.06%
3Y Avg
10.58%
5Y Avg
10.58%
Market Cap
$492.43M
Return on Equity (ROE)
89.43%
TTM Avg
81.07%
3Y Avg
67.39%
5Y Avg
61.90%
Market Cap
$1.18B
Return on Equity (ROE)
-13.54%
TTM Avg
-40.81%
3Y Avg
-170.75%
5Y Avg
-114.78%
Market Cap
$2.23B
Return on Equity (ROE)
-40.41%
TTM Avg
-45.75%
3Y Avg
-30.11%
5Y Avg
-18.95%
Market Cap
$3.06B
Return on Equity (ROE)
29.28%
TTM Avg
27.86%
3Y Avg
4.54%
5Y Avg
-12.45%
Market Cap
$5.00B
Return on Equity (ROE)
18.24%
TTM Avg
20.62%
3Y Avg
17.32%
5Y Avg
27.02%
Market Cap
$5.40B
Return on Equity (ROE)
8.67%
TTM Avg
8.42%
3Y Avg
7.80%
5Y Avg
5.80%
Market Cap
$6.43B
Return on Equity (ROE)
-43.83%
TTM Avg
25.09%
3Y Avg
5.57%
5Y Avg
0.40%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PDS Biotechnology Corporation (PDSB) | $11.79M | -372.85% | -397.37% | -164.30% | -137.61% |
| Shoulder Innovations, Inc. (SI)vs › | $438.82M | -28.18% | -0.06% | 10.58% | 10.58% |
| NRC Health (NRC)vs › | $492.43M | 89.43% | 81.07% | 67.39% | 61.90% |
| Teladoc Health, Inc. (TDOC)vs › | $1.18B | -13.54% | -40.81% | -170.75% | -114.78% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.23B | -40.41% | -45.75% | -30.11% | -18.95% |
| TransMedics Group, Inc. (TMDX)vs › | $3.06B | 29.28% | 27.86% | 4.54% | -12.45% |
| Doximity, Inc. (DOCS)vs › | $5.00B | 18.24% | 20.62% | 17.32% | 27.02% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.40B | 8.67% | 8.42% | 7.80% | 5.80% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.43B | -43.83% | 25.09% | 5.57% | 0.40% |
| Chemed Corporation (CHE)vs › | $6.84B | 33.11% | 27.03% | 27.48% | 31.41% |
ROE
-372.9%
ROA
-382.3%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-03-31 | -856.89% |
| 2025-12-31 | -372.85% |
| 2025-09-30 | -369.02% |
| 2025-06-30 | -229.34% |
| 2025-03-31 | -158.73% |
| 2024-12-31 | -197.90% |
| 2024-09-30 | -184.34% |
| 2024-06-30 | -131.57% |
| 2024-03-31 | -118.03% |
| 2023-12-31 | -164.33% |
| 2023-09-30 | -209.04% |
| 2023-06-30 | -147.20% |
| 2023-03-31 | -102.51% |
| 2022-12-31 | -92.85% |
| 2022-09-30 | -59.58% |
| 2022-06-30 | -53.62% |
| 2022-03-31 | -39.99% |
| 2021-12-31 | -26.77% |
| 2021-09-30 | -21.55% |
| 2021-06-30 | -15.85% |
| 2021-03-31 | -57.07% |
| 2020-12-31 | -54.73% |
| 2020-09-30 | -48.34% |
| 2020-06-30 | -99.00% |
| 2020-03-31 | -89.51% |
| 2019-12-31 | -59.83% |
| 2019-09-30 | -37.90% |
| 2019-06-30 | -21.45% |
| 2019-03-31 | -54.04% |
| 2018-12-31 | -69.59% |
| 2018-09-30 | -101.94% |
| 2018-06-30 | -115.77% |
| 2018-03-31 | -89.04% |
| 2017-12-31 | -81.54% |
| 2017-09-30 | -62.25% |
| 2017-06-30 | -54.53% |
| 2017-03-31 | -53.17% |
| 2016-12-31 | -43.48% |
| 2016-09-30 | -38.22% |
| 2016-06-30 | -34.32% |
| 2016-03-31 | -28.57% |
| 2015-12-31 | -22.93% |
| 2015-06-30 | -31.97% |
